Back to Search
Start Over
Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018.
- Source :
-
Antiviral research [Antiviral Res] 2019 Feb; Vol. 162, pp. 142-150. Date of Electronic Publication: 2018 Dec 28. - Publication Year :
- 2019
-
Abstract
- The Third Tofo Advanced Study Week on Emerging and Re-Emerging Viruses (3rd TASW) was held in Praia do Tofo, Mozambique, from September 02 to 06, 2018. It brought together 55 participants from 10 African countries as well as from Belgium, China, Germany, Singapore, and the USA. Meeting sessions covered aspects of the epidemiology, diagnosis, molecular and structural biology, vaccine development, and antiviral drug discovery for emerging RNA viruses that are current threats in Africa and included flaviviruses (dengue and Zika), alphaviruses (chikungunya), coronaviruses, filoviruses (Ebola), influenza viruses, Crimean Congo hemorrhagic fever virus, Rift Valley fever Virus, Lassa virus, and others. Data were presented on recent flavivirus and/or chikungunyavirus outbreaks in Angola, Burkina Faso, and Mozambique. In addition, these viruses are endemic in many sub-Saharan countries. The TASW series on emerging viruses is unique in Africa and successful in promoting collaborations between researchers in Africa and other parts of the world, as well as among African scientists. This report summarizes the lectures held at the meeting and highlights advances in the field.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Chikungunya Fever
Congresses as Topic
Disease Outbreaks
Flavivirus pathogenicity
Hemorrhagic Fever Virus, Crimean-Congo pathogenicity
Hemorrhagic Fever, Crimean
Hemorrhagic Fever, Ebola
Humans
Mozambique
Zika Virus pathogenicity
Communicable Diseases, Emerging virology
RNA Viruses pathogenicity
Subjects
Details
- Language :
- English
- ISSN :
- 1872-9096
- Volume :
- 162
- Database :
- MEDLINE
- Journal :
- Antiviral research
- Publication Type :
- Academic Journal
- Accession number :
- 30597184
- Full Text :
- https://doi.org/10.1016/j.antiviral.2018.12.015